131 related articles for article (PubMed ID: 28968819)
1. Type I interferonopathy in a young adult.
Manoussakis MN; Mavragani CP; Nezos A; Zampeli E; Germenis A; Moutsopoulos HM
Rheumatology (Oxford); 2017 Dec; 56(12):2241-2243. PubMed ID: 28968819
[No Abstract] [Full Text] [Related]
2. Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy.
Chia J; Eroglu FK; Özen S; Orhan D; Montealegre-Sanchez G; de Jesus AA; Goldbach-Mansky R; Cowen EW
J Am Acad Dermatol; 2016 Jan; 74(1):186-9. PubMed ID: 26584874
[TBL] [Abstract][Full Text] [Related]
3. A patient with stimulator of interferon genes-associated vasculopathy with onset in infancy without skin vasculopathy.
Raffaele CGL; Messia V; Moneta G; Caiello I; Federici S; Pardeo M; Bracaglia C; De Benedetti F; Insalaco A
Rheumatology (Oxford); 2020 Apr; 59(4):905-907. PubMed ID: 31598716
[No Abstract] [Full Text] [Related]
4. STING-associated vasculopathy with onset in infancy--a new interferonopathy.
Crow YJ; Casanova JL
N Engl J Med; 2014 Aug; 371(6):568-71. PubMed ID: 25029336
[No Abstract] [Full Text] [Related]
5. [Stimulator of interferon genes-associated vasculopathy with onset in infancy: first case report in China].
Yu ZX; Zhong LQ; Song HM; Wang CY; Wang W; Li J; Ma MS
Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):179-185. PubMed ID: 29518827
[No Abstract] [Full Text] [Related]
6. Dysregulation of the type I interferon system in adult-onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease.
Sun WC; Sun YC; Lin H; Yan B; Shi GX
Br J Dermatol; 2012 Dec; 167(6):1236-44. PubMed ID: 23013528
[TBL] [Abstract][Full Text] [Related]
7. STAT3 Gain of Function: A New Kid on the Block in Interstitial Lung Diseases.
Fabre A; Marchal S; Forbes LR; Vogel TP; Barlogis V; Triolo V; Rohrlich PS; Bérard E; Frankel D; Ambrosetti D; Soler C; Hoflack M; Baque M; Bosdure E; Baravalle M; Carsin A; Dubus JC; Giovannini-Chami L
Am J Respir Crit Care Med; 2018 Jun; 197(11):e22-e23. PubMed ID: 29590538
[No Abstract] [Full Text] [Related]
8. [Early aggressive systemic inflammatory vascular diseases: mutations in adenosine desaminase 2 and interferonopathies].
Dereure O
Ann Dermatol Venereol; 2014 Dec; 141(12):808-9. PubMed ID: 25433938
[No Abstract] [Full Text] [Related]
9. Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Mimic of Childhood Granulomatosis With Polyangiitis.
Munoz J; Rodière M; Jeremiah N; Rieux-Laucat F; Oojageer A; Rice GI; Rozenberg F; Crow YJ; Bessis D
JAMA Dermatol; 2015 Aug; 151(8):872-7. PubMed ID: 25992765
[TBL] [Abstract][Full Text] [Related]
10. Type I interferons as biomarkers in autoimmune diseases.
Kalliolias GD; Kirou KA
Biomark Med; 2012 Apr; 6(2):137-40. PubMed ID: 22448787
[No Abstract] [Full Text] [Related]
11. Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation).
Picard C; Thouvenin G; Kannengiesser C; Dubus JC; Jeremiah N; Rieux-Laucat F; Crestani B; Belot A; Thivolet-Béjui F; Secq V; Ménard C; Reynaud-Gaubert M; Reix P
Chest; 2016 Sep; 150(3):e65-71. PubMed ID: 27613991
[TBL] [Abstract][Full Text] [Related]
12. Autoinflammation: A new STING-associated monogenic autoinflammatory disease.
Onuora S
Nat Rev Rheumatol; 2014 Sep; 10(9):512. PubMed ID: 25090944
[No Abstract] [Full Text] [Related]
13. Interstitial Lung Disease Caused by STING-associated Vasculopathy with Onset in Infancy.
Clarke SL; Pellowe EJ; de Jesus AA; Goldbach-Mansky R; Hilliard TN; Ramanan AV
Am J Respir Crit Care Med; 2016 Sep; 194(5):639-42. PubMed ID: 27585386
[No Abstract] [Full Text] [Related]
14. More than meets the eye: IgG4-related disease presenting as isolated interstitial lung disease.
Jagpal A; Crowe DR; de Andrade JA; Del Pilar Acosta Lara M; Navarro-Millan I
Rheumatology (Oxford); 2017 Sep; 56(9):1630-1631. PubMed ID: 28582539
[No Abstract] [Full Text] [Related]
15. Novel heterozygous mutation of RTEL1 in interstitial pneumonia with autoimmune feature.
Yuan ZZ; Fan LL; Wang CY; Luo H; Liu L
QJM; 2022 Apr; 115(4):253-255. PubMed ID: 34894270
[No Abstract] [Full Text] [Related]
16. [Cutis marmorata telangiectatica congenita: Mutations in a susceptibility gene involved in cerebrovascular accidents].
Dereure O
Ann Dermatol Venereol; 2016 Jan; 143(1):96-7. PubMed ID: 26708206
[No Abstract] [Full Text] [Related]
17. [When to consider type I interferonopathy in adulthood?].
David C; Frémond ML
Rev Med Interne; 2022 Jun; 43(6):347-355. PubMed ID: 35177256
[TBL] [Abstract][Full Text] [Related]
18. STAT3 gain of function: a new aetiology of severe rheumatic disease.
Giovannini-Chami L; Vogel TP; Forbes LR; Fabre A; Trojani MC; Leroy S; Antunes O; Vincent-Mefitiot N; Hiéronimus S; Baque-Juston M; Roux C; Tieulié N
Rheumatology (Oxford); 2019 Feb; 58(2):365-367. PubMed ID: 30299506
[No Abstract] [Full Text] [Related]
19. A kindred of children with interstitial lung disease.
Thomas H; Risma KA; Graham TB; Brody AS; Deutsch GH; Young LR; Joseph PM
Chest; 2007 Jul; 132(1):221-30. PubMed ID: 17625084
[TBL] [Abstract][Full Text] [Related]
20. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.
Melki I; Rose Y; Uggenti C; Van Eyck L; Frémond ML; Kitabayashi N; Rice GI; Jenkinson EM; Boulai A; Jeremiah N; Gattorno M; Volpi S; Sacco O; Terheggen-Lagro SWJ; Tiddens HAWM; Meyts I; Morren MA; De Haes P; Wouters C; Legius E; Corveleyn A; Rieux-Laucat F; Bodemer C; Callebaut I; Rodero MP; Crow YJ
J Allergy Clin Immunol; 2017 Aug; 140(2):543-552.e5. PubMed ID: 28087229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
